Antibiotics Side Effects on the Mitochondria
Science is just beginning to understand how important your mitochondria are to warding off the diseases of aging. And, as usual, mainstream medicine is lagging way behind. Along with your telomeres, the cellular time keepers at the ends of your chromosomes, your mitochondria are another key component of the anti-aging equation. You see, these tiny organelles in your cells are the power plants that turn fuel into energy for your body. Healthy mitochondria keep you young and energetic. Research shows that damaged mitochondria can lead to: Schizophrenia and bipolar disorder; Alzheimer’s and Parkinson’s disease; Epilepsy, migraines, and nerve pain; Loss of muscle control and balance; Strokes, heart disease, and coronary artery disease; Chronic fatigue syndrome and fibromyalgia; Blindness; Diabetes; Hepatitis C and cirrhosis.1 Now new research reveals that antibiotics smother your mitochondria. I’ve been warning about the side effects of antibiotics for years. Yes, they’ve saved many lives. But rampant overuse of these drugs has left us with a slew of health problems. Antibiotic Side Effects on The Gut Antibiotics destroy the good bacteria that make up your gut’s flora. They impact digestion, the immune system, and the endocrine system. Now a study in the journal, Cell Reports, has raised the alarm about tetracyclines.2 These drugs are used for bacterial infections. They treat urinary tract infections, acne, malaria, Lyme disease, r...
We describe the most highly recommended generic and disease-specific PRO tools in SCD and discuss the challenges of incorporating them in clinical practice. EXPERT OPINION: PRO measures are essential to incorporate into SCD clinical trials either as primary or secondary outcomes. The use of PRO measures in SCD facilitates a patient-centered approach, which is likely to lead to improved outcomes. Significant challenges remain in adapting PRO tools to routine clinical use and in developing countries. PMID: 33034214 [PubMed - as supplied by publisher]
Publication date: Available online 10 October 2020Source: Journal of Genetics and GenomicsAuthor(s): Chengqi Wang, Justin Gibbons, Swamy R. Adapa, Jenna Oberstaller, Xiangyun Liao, Min Zhang, John H. Adams, Rays H.Y. Jiang
Publication date: Available online 10 October 2020Source: Meta GeneAuthor(s): Mansour Zamanpoor, Hamid Ghaedi, Mir Davood Omrani
Authors: Sabet Sarvestani F, Azarpira N Abstract Heart and cerebral infarctions, as two important ischemic diseases, lead to the death of tissues due to inadequate blood supply and high mortality worldwide. These statuses are started via blockage of vessels and depletion of oxygen and nutrients which affected these areas. After reperfusion and restoration of oxygen supply, more severe injury was mediated by multifaceted cascades of inflammation and oxidative stress. microRNAs (miRNAs) as the regulator of biological and pathological pathways can adjust these conditions by interaction with their targets. Also, miRNAs...
Currently in fellowship doing bread/butter procedures (MBB, epidurals, PNB, few SCS/PNS trials, etc.) and just interviewed at a private practice spot where they do a lot of procedures that I will have not done any training in prior to graduating (e.g. IT pump, SI fusion, Vertiflex, Kypho, MILD, Discectomy, lots of SCS/PNS trials etc) and significant amount of "OR pain procedures" at a very busy practice seeing 30-40 pts/day - how many of you are commonly performing these procedures and are... private practice concern
Publication date: Available online 9 October 2020Source: Clinical Plasma MedicineAuthor(s): Dr. Arisi Mariachiara, Venturuzzo Anna, Gelmetti Alessandra, Guasco Pisani Edoardo, Bassissi Stefania, Rossi Mariateresa, Calzavara-Pinton Piergiacomo
CONCLUSION: The proposed PHARMAC criteria will give access to these important drugs to those people with T2DM who will likely benefit the most. PMID: 33032305 [PubMed - in process]
CONCLUSION: This study found that childhood cancer survivors in New Zealand had a high prevalence of developmental dental abnormalities and it identified potential risk factors related to their cancer treatment. Inequitable access to oral rehabilitation for this patient group argues for a mechanism for consistent improved access to publicly funded dental care across district health boards in New Zealand. PMID: 33032302 [PubMed - in process]
Authors: Siamashvili M, Davis S Abstract INTRODUCTION: Bromocriptine mesylate quick release (QR) is a dopamine D2 receptor agonist and is the only oral, primarily centrally acting drug that can be used for the treatment of adults with type 2 diabetes. AREAS COVERED: The authors describe current recommendations on the use of bromocriptine mesylate QR. Major efficacy and safety parameters of the late phase trials, including The Cycloset Safety Trial, have been identified and presented. EXPERT OPINION: Efficacy of bromocriptine mesylate QR monotherapy appears to be low but is compensated by favorable safety pr...
More News: Acne | Arthritis | Bananas | Bipolar | Blindness | Boston University | Brain | Cabbage | Cardiology | Chemistry | Children | Chronic Fatigue Syndrome | Chronic Pain | Cipro | Ciprofloxacin | Cirrhosis | Complementary Medicine | Diabetes | Endocrinology | Epilepsy | Fibromyalgia | Headache | Health | Heart | Heart Disease | Hepatitis | Hepatitis C | Kiwi | Lyme Disease | Malaria | Mania | Migraine | Mitochondria | Mitochondrial Disease | Neurology | Neuroscience | Neurosurgery | Nutrition | Opthalmology | Pain | Pain Management | Peppers | Rheumatoid Arthritis | Rheumatology | Schizophrenia | Science | Sports Medicine | Stem Cell Therapy | Stem Cells | Stroke | Study | Sweet Potato | Tetracycline | Training | Universities & Medical Training | Urinary Tract Infections | Warnings